WHO GRADE 2 GLIOMA
Clinical trials for WHO GRADE 2 GLIOMA explained in plain language.
Never miss a new study
Get alerted when new WHO GRADE 2 GLIOMA trials appear
Sign up with your email to follow new studies for WHO GRADE 2 GLIOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New pill vs. standard IV chemo: major trial for Kids' brain tumors
Disease control Recruiting nowThis study is for children and young adults (ages 2-21) with a specific type of slow-growing brain tumor called low-grade glioma. It compares a newer oral drug, selumetinib, to the current standard intravenous chemotherapy (carboplatin and vincristine). The main goal is to see if…
Matched conditions: WHO GRADE 2 GLIOMA
Phase: PHASE3 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Mar 30, 2026 14:29 UTC
-
New immune therapy tested in fight against recurrent brain cancer
Disease control Recruiting nowThis is a first-in-human study to test the safety and find the right dose of a new CAR T-cell therapy for adults with recurrent high-grade glioma, a serious brain cancer. Doctors will take a patient's own immune cells, modify them in a lab to target a protein called GARP on the t…
Matched conditions: WHO GRADE 2 GLIOMA
Phase: PHASE1 • Sponsor: Ohio State University Comprehensive Cancer Center • Aim: Disease control
Last updated Mar 23, 2026 15:19 UTC